Two Sigma Investments’s Genprex GNPX Stock Holding History

Two Sigma Investments’s Portfolio GNPX Stock Details GNPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2	Closed	-$95K	–	3312
2021 Q4	$95K	Buy	+2	New	+$167K	﹤0.01%	4067

Other funds holding GNPX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cypress Capital Franklin, Tennessee $370M AUM 16.36% 1-Year Est. Return

Two Sigma Investments's GNPX Position: Q1 2022 in Review

Two Sigma Investments sold out of Genprex (GNPX) in Q1 2022, closing a stake of 2 shares — an estimated $95K sold.

Two Sigma Investments first reported a position in GNPX in Q4 2021 and held it in 1 quarter. The position peaked at $95K in Q4 2021. 20 funds tracked by Wall St. Rank hold GNPX as of Q1 2022.

Two Sigma Investments reported no remaining Genprex position as of Q1 2022 after selling out during the quarter.
Two Sigma Investments sold 2 Genprex shares in Q1 2022, an estimated $95K.
Two Sigma Investments first reported a position in Genprex in Q4 2021 and held it in 1 quarter.
Two Sigma Investments's Genprex position peaked at $95K in Q4 2021.
20 funds tracked by Wall St. Rank held Genprex as of Q1 2022.

Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.